SCHEMBL5899461

SCHEMBL5899461

CC(C)(NS(=O)(=O)Cc1cc(Cl)cc(Cl)c1)C(=O)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 3/20 0.47
STS P08842 1/20 0.40
BCL2L1 Q07817 2/20 0.38
MCL1 Q07820 2/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
S100A9 P06702 5/20 0.38
KAT6A Q92794 1/20 0.37
HPGD P15428 1/20 0.37
GRN P28799 1/20 0.36
SORT1 Q99523 1/20 0.36
TACR1 P25103 1/20 0.36
MEN1 O00255 1/20 0.36
PLA2G1B P04054 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
GAA P10253 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899426 0.88 ALDH1A1 (0.46) MCL1HPGDMEN1CYP3A4CYP2D6
SCHEMBL5899466 0.86 CA1 (0.50) STSMAPTHPGDGAAKMT2A
SCHEMBL14675961 0.75 CA1 (0.55) STSHPGDKMT2A
SCHEMBL5899559 0.75 ACLY (0.51) ACLYBCL2L1MCL1LMNATP53
SCHEMBL14675973 0.75 ALDH1A1 (0.46) HPGDMEN1CYP3A4GAAKMT2A
SCHEMBL5899422 0.72 FLT1 (0.57) LMNAMAPTMEN1GAAKMT2A
SCHEMBL5963267 0.72 CA1 (0.55) STSHPGDMEN1KMT2A
SCHEMBL14677077 0.71 S100A9 (0.44) LMNAMAPTS100A9HPGDCYP3A4
SCHEMBL4994999 0.70 ALDH1A1 (0.50) HPGDMEN1CYP1A2CYP3A4GAA
SCHEMBL14676871 0.70 ALDH1A1 (0.54) LMNAMAPTHPGDCYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 ACLY 1905/4885STS 66/4885BCL2L1 2196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.